Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-29 Purchase | 2022-10-03 4:42 pm | Syros Pharmaceuticals Inc. | SYRS | TYSON TIMOTHY Director | 16,932 | $6.2577 | $105,955 | 24,932 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-11 Option Award | 2022-10-13 4:20 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-10-11 Ownership | 2022-10-13 4:15 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal Officer | 0 | $0 | 50,702 (Direct) | View |
| 2022-10-06(A) Option Award | 2022-10-11 4:55 pm | N/A 2032-10-05 | Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer | 78,500 | $0 | 78,500 (Direct) | View |
| 2022-10-11 Option Award | 2022-10-11 4:40 pm | N/A 2032-10-05 | Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer | 78,500 | $0 | 78,500 (Direct) | View |
| 2022-10-06 Option Award | 2022-10-11 4:39 pm | N/A 2032-10-05 | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 78,500 | $0 | 78,500 (Direct) | View |
| 2022-10-06 Option Award | 2022-10-11 4:38 pm | N/A 2032-10-05 | Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer | 78,500 | $0 | 78,500 (Direct) | View |
| 2022-10-06 Option Award | 2022-10-11 4:38 pm | N/A 2032-10-05 | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 87,500 | $0 | 87,500 (Direct) | View |
| 2022-10-06 Option Award | 2022-10-11 4:37 pm | N/A 2032-10-05 | Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer | 87,500 | $0 | 87,500 (Direct) | View |
| 2022-10-06 Option Award | 2022-10-11 4:36 pm | N/A 2032-10-05 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 195,250 | $0 | 195,250 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:16 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:15 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | WIRTH PETER Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:14 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | TYSON TIMOTHY Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:14 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | OH ANDREW M. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:13 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | Fanucci Marsha Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:09 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | Eckhardt Sue Gail Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:08 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:08 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:07 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 7:10 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 7:10 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 7:09 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 7:09 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | WIRTH PETER Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 7:08 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | SHARP PHILLIP A Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 7:08 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 7:07 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | Fanucci Marsha Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 7:07 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | Eckhardt Sue Gail Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 7:06 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-04 5:04 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 14,115 | $1.12 | 30,885 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-04 5:03 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 27,281 | $1.12 | 59,719 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-04 5:02 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer | 27,266 | $1.12 | 59,734 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-04 5:02 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 58,883 | $1.12 | 692,723 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 4:10 pm | N/A 2032-02-14 | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 405,000 | $0 | 405,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 4:09 pm | N/A 2032-02-14 | Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer | 180,000 | $0 | 180,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 4:08 pm | N/A 2032-02-14 | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 380,000 | $0 | 380,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 4:08 pm | N/A 2032-02-14 | Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer | 380,000 | $0 | 380,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 4:07 pm | N/A 2032-02-14 | Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer | 205,000 | $0 | 205,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 4:05 pm | N/A 2032-02-14 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 1,015,000 | $0 | 1,015,000 (Direct) | View |